Get started
Author

Zhiguo Hou

Neoadjuvant chemotherapy with or without camrelizumab in resectable esophageal squamous cell carcinoma: the randomized phase 3 ESCORT-NEO/NCCES01 trial
2024 · Jianjun Qin, Liyan Xue, et al. · Nature Medicine · 282
Phase II, single-arm trial of preoperative short-course radiotherapy followed by chemotherapy and camrelizumab in locally advanced rectal cancer
2021 · Zhenyu Lin, Ming Cai, et al. · Journal for ImmunoTherapy of Cancer · 174
PDF
Apatinib Plus Gefitinib as First-Line Treatment in Advanced EGFR-Mutant NSCLC: The Phase III ACTIVE Study (CTONG1706)
2021 · Hongyun Zhao, Wenxiu Yao, et al. · Journal of Thoracic Oncology · 123
PDF
Apatinib vs Placebo in Patients With Locally Advanced or Metastatic, Radioactive Iodine–Refractory Differentiated Thyroid Cancer
2021 · Yansong Lin, Shukui Qin, et al. · JAMA Oncology · 95
PDF
The Neo-PLANET phase II trial of neoadjuvant camrelizumab plus concurrent chemoradiotherapy in locally advanced adenocarcinoma of stomach or gastroesophageal junction
2022 · Zhaoqing Tang, Yan Wang, et al. · Nature Communications · 93
PDF
Camrelizumab plus apatinib as second-line treatment for advanced oesophageal squamous cell carcinoma (CAP 02): a single-arm, open-label, phase 2 trial
2022 · Xiangrui Meng, Tao Wu, et al. · The Lancet. Gastroenterology & hepatology · 88
Effect of Apatinib Plus Pegylated Liposomal Doxorubicin vs Pegylated Liposomal Doxorubicin Alone on Platinum-Resistant Recurrent Ovarian Cancer
2022 · Tiantian Wang, Jie Tang, et al. · JAMA Oncology · 83
PDF
Screening, Verification, and Optimization of Biomarkers for Early Prediction of Cardiotoxicity Based on Metabolomics
2015 · Yubo Li, Liang Ju, et al. · Journal of Proteome Research · 79
Perioperative camrelizumab plus rivoceranib versus surgery alone in patients with resectable hepatocellular carcinoma at intermediate or high risk of recurrence (CARES-009): a randomised phase 2/3 trial
2025 · Zheng Wang, Jia Fan, et al. · The Lancet · 74
First-line camrelizumab (a PD-1 inhibitor) plus apatinib (an VEGFR-2 inhibitor) and chemotherapy for advanced gastric cancer (SPACE): a phase 1 study
2024 · Xiaofeng Chen, Hao Xu, et al. · Signal Transduction and Targeted Therapy · 51
PDF
(±)-Praeruptorin A enantiomers exert distinct relaxant effects on isolated rat aorta rings dependent on endothelium and nitric oxide synthesis
2010 · Zhao Xu, Xiaobing Wang, et al. · Chemico-Biological Interactions · 48
Separation of minor coumarins from Peucedanum praeruptorum using HSCCC and preparative HPLC guided by HPLC/MS
2010 · Zhiguo Hou, Jianguang Luo, et al. · Separation and Purification Technology · 44
An application of high-speed counter-current chromatography coupled with electrospray ionization mass spectrometry for separation and online identification of coumarins from Peucedanum praeruptorum Dunn
2009 · Zhiguo Hou, Deran Xu, et al. · Journal of Chromatography B · 43
Polymorphisms in Inflammasome Genes and Risk of Coal Workers' Pneumoconiosis in a Chinese Population
2012 · Xiaoming Ji, Zhiguo Hou, et al. · PLoS ONE · 40
PDF
Safety and efficacy of apatinib in patients with advanced gastric or gastroesophageal junction adenocarcinoma after the failure of two or more lines of chemotherapy (AHEAD): a prospective, single-arm, multicenter, phase IV study
2023 · Jin Li, Shukui Qin, et al. · BMC Medicine · 37
PDF
A novel approach to the simultaneous extraction and non-targeted analysis of the small molecules metabolome and lipidome using 96-well solid phase extraction plates with column-switching technology
2015 · Yubo Li, Zhenzhu Zhang, et al. · Journal of Chromatography A · 37
Metabolomics study on primary dysmenorrhea patients during the luteal regression stage based on ultra performance liquid chromatography coupled with quadrupole-time-of-flight mass spectrometry
2017 · Ling Fang, Caiyun Gu, et al. · Molecular Medicine Reports · 33
PDF
A genome-wide association study identifies susceptibility loci of silica-related pneumoconiosis in Han Chinese
2014 · Minjie Chu, Xiaoming Ji, et al. · Human Molecular Genetics · 33
A Systematic Strategy for Screening and Application of Specific Biomarkers in Hepatotoxicity Using Metabolomics Combined With ROC Curves and SVMs
2016 · Yubo Li, Lei Wang, et al. · Toxicological Sciences · 31
Efficacy and safety of camrelizumab plus apatinib in patients with advanced esophageal squamous cell carcinoma previously treated with immune checkpoint inhibitors (CAP 02 Re-challenge): A single-arm, phase II study
2024 · Xiangrui Meng, Junsheng Wang, et al. · European Journal of Cancer · 25
Comprehensive multi‐omics analysis of resectable locally advanced gastric cancer: Assessing response to neoadjuvant camrelizumab and chemotherapy in a single‐center, open‐label, single‐arm phase II trial
2024 · Yuzhou Zhao, Danyang Li, et al. · Clinical and Translational Medicine · 25
A Novel Method for Evaluating the Cardiotoxicity of Traditional Chinese Medicine Compatibility by Using Support Vector Machine Model Combined with Metabonomics
2016 · Yubo Li, Haonan Zhou, et al. · Evidence-based Complementary and Alternative Medicine · 25
PDF
Rapid classification and identification of complex chemical compositions in traditional Chinese medicine based on UPLC-Q-TOF/MS coupled with data processing techniques using the KuDieZi injection as an example
2015 · Lei Yuan, Zhenzhu Zhang, et al. · Analytical Methods · 25
Screening and validation for plasma biomarkers of nephrotoxicity based on metabolomics in male rats
2015 · Yubo Li, Haoyue Deng, et al. · Toxicology Research · 24
PDF
The classification and identification of complex chemical compositions in yanhusuo herb using UPLC-Q-TOF/MS
2016 · Lei Yuan, Jia Yin, et al. · Analytical Methods · 23
Works count: 58
Citation count: 1,885
H-index: 24
I10-index: 36
Year
Topic
Type